BridgeBio Pharma (BBIO) Insider Trading & Ownership

$25.90

+0.94 (+3.77%)

(As of 10/11/2024 ET)

Current Insider Ownership Percentage: 24.66%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 6
Amount Of Insider Selling (Last 12 Months): $154.64 M

Get BBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling BridgeBio Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BBIO Insider Buying and Selling by Quarter

Ad Porter & Company

War on Elon Escalates…

Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

Click here to learn how you can benefit from its widespread distribution.

BridgeBio Pharma Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/13/2024	Genetic Disorder L.P. Kkr	Major Shareholder	Sell	5,800,000	$25.75	$149,350,000.00
8/19/2024	Brian C Stephenson	CFO	Sell	4,155	$24.69	$102,586.95
8/19/2024	Neil Kumar	CEO	Sell	27,389	$24.69	$676,234.41
6/3/2024	Randal W Scott	Director	Sell	1,000	$28.84	$28,840.00
3/1/2024	Randal W Scott	Director	Sell	2,500	$34.00	$85,000.00
1/16/2024	Hannah Valantine	Director	Sell	2,915	$37.97	$110,682.55
12/26/2023	Frank Mccormick	Director	Sell	100,000	$42.06	$4,206,000.00
12/18/2023	Randal W Scott	Director	Sell	2,000	$40.00	$80,000.00

(Data available from 1/1/2013 forward)

BBIO Insider Trading Activity - Frequently Asked Questions

: The list of insiders at BridgeBio Pharma includes Brian C Stephenson, Douglas A Dachille, Frank Mccormick, Genetic Disorder L.P. Kkr, Global Investors Lp Viking, Hannah Valantine, Neil Kumar, Randal W Scott, and Ronald J Daniels. Learn more on insiders at BBIO.
: 24.66% of BridgeBio Pharma stock is owned by insiders. Learn more on BBIO's insider holdings.
: The following insiders have sold BBIO shares in the last 24 months: Brian C Stephenson ($4,188,059.78), Frank Mccormick ($4,206,000.00), Genetic Disorder L.P. Kkr ($149,350,000.00), Global Investors Lp Viking ($52,500,000.00), Hannah Valantine ($110,682.55), Neil Kumar ($9,178,900.21), and Randal W Scott ($193,840.00).
: Insiders have sold a total of 8,427,275 BridgeBio Pharma shares in the last 24 months for a total of $219,727,482.54 sold.